P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.

• Clementine Sarkozy,
• Catherine Thieblemont,
• Lucie Oberic,
• Anne Moreau,
• Kamal Bouabdallah,
• Gandhi Laurent Damaj,
• Thomas Gastinne,
• Vincent Ribrag,
• Rene Olivier Casasnovas,
• Corinne Haioun,
• Roch Houot,
• Fabrice Jardin,
• Eric Van Den Neste,
• Morgane Cheminant,
• Franck Morschhauser,
• Mary Callanan,
• Herve Ghesquieres,
• Remy Gressin,
• Olivier Hermine,
• Steven Le Gouill

Affiliations

Clementine Sarkozy

1 Curie, Hematology, Saint Cloud, France

Catherine Thieblemont

2 APHP, Saint Louis, Paris, France

Lucie Oberic

3 IUCT, Oncopole, Toulouse, France

Anne Moreau

4 CHU Nantes, Nantes, France

Kamal Bouabdallah

5 CHU Bordeaux, Bordeaux, France

Gandhi Laurent Damaj

6 CHU Caen, Caen, France

Thomas Gastinne

4 CHU Nantes, Nantes, France

Vincent Ribrag

7 gustave roussy, Villejuif, France

Rene Olivier Casasnovas

8 CHU Dijon, Dijon, France

Corinne Haioun

9 Henri-Mondor University Hospital, Créteil, France

Roch Houot

10 CHU Rennes, Rennes, France

Fabrice Jardin

11 Centre Henri Becquerel, Rouen, France

Eric Van Den Neste

12 UCL, Louvain, Belgium

Morgane Cheminant

13 APHP, Necker, paris, France

Franck Morschhauser

14 CHU Lille, Lille, France

Mary Callanan

8 CHU Dijon, Dijon, France

Herve Ghesquieres

15 CHU Lyon Sud, Pierre Bénite, France

Remy Gressin

16 CHU Grenoble, Grenoble, France

Olivier Hermine

17 Necker, Paris, France

Steven Le Gouill

1 Curie, Hematology, Saint Cloud, France